American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

A new survey has shown which companies in Denmark are trusted the most and least. Novo Nordisk is at the top, followed by ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. The ...

Denmark will increase its military budget by a combined 50 billion crowns ($6.99 billion) this year and next to address acute ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Approval Drop. In this article, we ...

Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift ...

Novo Nordisk has its headquarters in Bagsvaerd in Denmark, and was founded in 1923. Among its products is semaglutide, sold under the brand names Ozempic and Wegovy, the latter of which has been ...

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Novo Nordisk is growing its India-based global business services to fill out vertical stacks, expand horizontal functions, ...

So, despite mounting competition, the Denmark-based drugmaker should remain a leader in GLP-1 drugs. Novo Nordisk has been looking to diversify its lineup in recent years, and is developing ...